OncologyTube Professional - Patients Click Here
GiDebates2017
24,129 video views
GiDebates2017: Videos
03:16
Howard S. Hochster, MD of Yale School of Medicine gives an overview of his presentation, The Impact of Molecular Subsets on Adjuvant and Advanced Disease Treatment, which was discussed at the 2017 Great Debates and Updates in GI Malignancies in New York, NY.
by:GiDebates2017 | 486 views
02:26
Howard S. Hochster, MD of Yale School of Medicine discusses the importance of recommending molecular testing early on to patients with colon cancer. He further explains the significance of HER2 testing in colon cancer. This was recorded at the 2017 Great Debates and Updates in GI Malignancies in New York, NY.
by:GiDebates2017 | 557 views
01:25
Howard S. Hochster, MD of Yale School of Medicine discusses the impact of molecular testing and screening on potential clinical trials at the 2017 Great Debates and Updates in GI Malignancies in New York, NY.
by:GiDebates2017 | 545 views
02:48
Christopher Crane, MD of Memorial Sloan-Kettering gives an overview of his presentation, What is the Optimal Neoadjuvant Strategy in Pancreatic Cancer, which was debated at the 2017 Great Debates and Updates in GI Malignancies in New York, NY.
by:GiDebates2017 | 800 views
03:16
Christopher Crane, MD of Memorial Sloan-Kettering gives an overview of his presentation, Does Radiation Therapy Play a Role in Gastric Cancer Adjuvant Therapy, which was debated with Dr. David Ilson, MD, PhD of Memorial Sloan-Kettering. This was recorded at the 2017 Great Debates and Updates in GI M...
by:GiDebates2017 | 679 views
02:34
Mark A. Schattner, MD of Memorial Sloan-Kettering gives an overview of his presentation, Novel Endoscopic Management of Pancreaticobili​ary Cancers, which was presented at the 2017 Great Debates and Updates in GI Malignancies in New York, NY.
by:GiDebates2017 | 622 views
01:13
Mark A. Schattner, MD of Memorial Sloan-Kettering explains whether or not there is screen for pancreatic cancer. This was recorded at the 2017 Great Debates and Updates in GI Malignancies in New York, NY.
by:GiDebates2017 | 558 views
00:46
David Ilson, MD, PhD of Memorial Sloan-Kettering discusses questions from the audience that focused on the appropriate chemotherapy for gastric cancer treatment. This was recorded at the 2017 Great Debates and Updates in GI Malignancies in New York, NY.
by:GiDebates2017 | 700 views
00:52
David Ilson, MD, PhD of Memorial Sloan-Kettering explains the impact of radiation therapy on clinical practice. He argues that adding radiation therapy as an obligatory part of adjuvant therapy does not improve overall survival. This was recorded at the 2017 Great Debates and Updates in GI Malignancies in New York, NY.
by:GiDebates2017 | 610 views
02:12
David Ilson, MD, PhD of Memorial Sloan-Kettering gives an overview of his presentation, Debate: Does Radiation Therapy Play a Role in Gastric Cancer Adjuvant Therapy, which was debated with Dr. Christopher Crane, MD of Memorial Sloan-Kettering. He argues that adjuvant radiation therapy adds no benef...
by:GiDebates2017 | 530 views
dsfsd